Nottingham University Hospitals NHS Trust (NUH) is one of the largest Trusts in Europe, with 2,200 hospital beds and over 13,000 staff based on two campuses – the Queen’s Medical Centre (QMC) and Nottingham City Hospital.
The Trust incorporates all major medical and surgical subspecialties. It is a tertiary referral centre for the East Midlands. Along with general modules, trainees undertake their Cardiothoracic, Neurosurgical and Paediatric and neonatal training within NUH. The last few years have seen a number of exciting major developments including designation of QMC as the East Midlands Major Trauma Centre (EMMTC) and futher expansion of Critical Care. A state of the art Diagnostic and Treatment Centre operated by Circle Healthcare on behalf of the NHS was also opened on QMC Campus in 2008, which provides Consultant-delivered Daycase capacity.
NUH enjoys close links with the region’s Universities and attracts and develops the highest calibre of staff. The work being carried out by NUH researchers has led to a reputation for excellence and is making a very real difference to people’s lives. The Trust continues to attract and encourage investment and remains at the forefront of research.
As part of a national clinical research collaboration, the Trust is a UK co-ordinating centre for numerous clinical trials. We have an active, well regarded Academic Department of Anaesthesia and Trainees are encouraged to participate in research projects. In the past, trainees have presented their work at worldwide conferences.
There are Postgraduate Centres and libraries on both campuses. The Trent Simulation and Clinical Skills Centrespecialises in clinical skills, human factors and patient safety training. The centre offers a number of relevant courses to anaesthetists using the high fidelity simulators. There are also opportunities to become actively involved in teaching.
2015 sees QMC becoming the first hospital in the country with a tram station as part of the Nottingham Express Transit (NET) Project which will improving access for staff and patients, and development of the £5.5m Medipark research facility.